Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 7/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | ESR1 | P03372 | 3/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 2/20 | 0.38 |
| ▸ | CNR2 | P34972 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | TYR | P14679 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.34 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14859460 | 0.86 | ERN1 (0.55) | ERN1ALDH1A1CA2POLBTYR | |
| SCHEMBL30829192 | 0.86 | ERN1 (0.55) | ERN1ALDH1A1CA2POLBTYR | |
| SCHEMBL30829189 | 0.86 | ESR1 (0.44) | ERN1ALDH1A1ESR1ESR2CYP3A4 | |
| SCHEMBL3241119 | 0.86 | ESR1 (0.44) | ERN1ALDH1A1ESR1ESR2CYP3A4 | |
| SCHEMBL15771550 | 0.85 | ALOX5 (0.48) | ERN1ALDH1A1ESR1ESR2CYP3A4 | |
| SCHEMBL2197374 | 0.84 | ERN1 (0.51) | ERN1ALDH1A1ESR1ESR2CYP3A4 | |
| SCHEMBL13445622 | 0.82 | MAPT (0.38) | ERN1ALDH1A1ESR1ESR2CYP3A4 | |
| SCHEMBL14320100 | 0.81 | ALOX5 (0.38) | ERN1ALDH1A1ESR1ESR2CYP3A4 | |
| SCHEMBL6446758 | 0.81 | ERN1 (0.45) | ERN1ALDH1A1CYP3A4CA2TYR | |
| SCHEMBL1685290 | 0.80 | ERN1 (0.47) | ERN1ALDH1A1ESR1ESR2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117430525-A | Schiff base ligand and preparation method and application thereof | 中化学科学技术研究有限公司 | 2024-01-23 | — | — | CN | disclosed |
| EP-2174928-B1 | TRANSITION METAL COMPLEX COMPOUND, OLEFIN OLIGOMERIZATION CATALYST CONTAINING THE COMPOUND, AND METHOD FOR PRODUCING OLEFIN OLIGOMER PERFORMED IN THE PRESENCE OF THE CATALYST | MITSUI CHEMICALS INC (JP) | 2015-03-11 | — | — | EP | disclosed |
| US-8258361-B2 | Transition metal complex compounds, olefin oligomerization catalysts including the compounds, and processes for producing olefin oligomers using the catalysts | MITSUI CHEMICALS, INC. (JP) | 2012-09-04 | — | — | US | disclosed |
| US-20110082325-A1 | TRANSITION METAL COMPLEX COMPOUNDS, OLEFIN OLIGOMERIZATION CATALYSTS INCLUDING THE COMPOUNDS, AND PROCESSES FOR PRODUCING OLEFIN OLIGOMERS USING THE CATALYSTS | MITSUI CHEMICALS, INC. | 2011-04-07 | — | — | US | disclosed |
| EP-2178537-A1 | BETA CARBOLINE DERIVATIVES AS ANTIDIABETIC COMPOUNDS | Merck Sharp & Dohme Corp. (US) | 2010-04-28 | — | — | EP | disclosed |
| EP-2174928-A1 | TRANSITION METAL COMPLEX COMPOUND, OLEFIN POLYMERIZATION CATALYST CONTAINING THE COMPOUND, AND METHOD FOR PRODUCING OLEFIN POLYMER PERFORMED IN THE PRESENCE OF THE CATALYST | Mitsui Chemicals, Inc. (JP) | 2010-04-14 | — | — | EP | disclosed |
| US-7687579-B2 | Ethylene (co) polymer and its use | MITSUI CHEMICALS, INC. (JP) | 2010-03-30 | — | — | US | disclosed |
| US-7563849-B2 | Ethylene (co) polymer and its use | MITSUI CHEMICALS, INC. (JP) | 2009-07-21 | — | — | US | disclosed |
| WO-2009011836-A1 | BETA CARBOLINE DERIVATIVES AS ANTIDIABETIC COMPOUNDS | MERCK & CO., INC. (US) | 2009-01-22 | — | — | WO | disclosed |
| US-7335716-B1 | Ethylene (co)polymers and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2008-02-26 | — | — | US | disclosed |
| US-20060047096-A1 | Ethylene (co) polymer and its use | TAKAHASHI MAMORU | 2006-03-02 | — | — | US | disclosed |
| US-20060047079-A1 | Ethylene (co) polymer and its use | TAKAHASHI MAMORU | 2006-03-02 | — | — | US | disclosed |
| US-6962890-B2 | Olefin polymerization catalyst and process for olefin polymerization using the olefin polymerization catalyst | MITSUI CHEMICALS, INC. (JP) | 2005-11-08 | — | — | US | disclosed |
| EP-1582533-A1 | Ethylene (co)polymer and its use | MITSUI CHEMICALS, INC. (JP) | 2005-10-05 | — | — | EP | disclosed |
| EP-1013674-B1 | Olefin polymerization catalyst and process for olefin polymerization using this catalyst | MITSUI CHEMICALS INC (JP) | 2005-04-27 | — | — | EP | disclosed |
| US-20030027955-A1 | Olefin polymerization catalyst, process for polymerizing olefins, ethylene polymer obtained by said process and use thereof | MITSUI CHEMICALS, INC. (JP) | 2003-02-06 | — | — | US | disclosed |
| EP-1270603-A2 | Olefin polymerization catalyst, process for polymerizing olefins, ethylene polymer obtained by said process and use thereof | Mitsui Chemicals, Inc. (JP) | 2003-01-02 | — | — | EP | disclosed |
| US-20030004290-A1 | Olefin polymerization catalyst and process for olefin polymerization using the olefin polymerization catalyst | MITSUI CHEMICALS, INC. | 2003-01-02 | — | — | US | disclosed |
| EP-1162211-A1 | ETHYLENE (CO)POLYMERS AND USES THEREOF | Mitsui Chemicals, Inc. (JP) | 2001-12-12 | — | — | EP | disclosed |
| EP-1013674-A1 | Olefin polymerization catalyst and process for olefin polymerization using this catalyst | Mitsui Chemicals, Inc. (JP) | 2000-06-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110082325-A1 | TRANSITION METAL COMPLEX COMPOUNDS, OLEFIN OLIGOMERIZATION CATALYSTS INCLUDING THE COMPOUNDS, AND PROCESSES FOR PRODUCING OLEFIN OLIGOMERS USING THE CATALYSTS | OSTC, COG4, COG7 | ERN1 2069/4885ALDH1A1 2282/4885ESR1 1772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.